However, since MEN4 presents a clinical phenotype overlapping that of MEN1, it is highly probable that PHPT-related hypercalcemia can alter bone metabolism and reduce BMD value the same way we find in MEN1 patients (Table 1). The gene discussed is MEN1; the disease is Hypercalcemia.